A case of inclusion body myositis with systemic sclerosis

Modern Rheumatology

Volumn 13, Issue 1, 2003, Pages 87-89

  Kusaoi, Makio ^a   Fukazawa, Toru ^a   Hirashima, Mika ^a   Morita, Yuko ^a   Yamaji, Chiharu ^a   Takai, Shuuhei ^a   Takasaki, Yoshinari ^a   Hashimoto, Hiroshi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoimmune disease; Corticosteroids; Inclusion body myositis (IBM); Rimmed vacuoles

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; HUMAN; INCLUSION BODY MYOSITIS; LEG MUSCLE; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 0043175058     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101650300014     Document Type: Article

References (13)

1. Lotz BP, Engel AG, Nishio H, Stevens JC, Litchy WJ. Inclusion body myositis: observations on 40 patients. Brain 1989;112:727-47.
2. Yunis EJ, Samaha FJ. Inclusion body myositis. Lab Invest 1971;25:240-7.
3. Askanas V, Engel WK. New advances in inclusion body myositis. Curr Opin Rheumatol 1993;5:732-41.
4. Sekul EA, Dalakas MC. Inclusion body myositis: new concepts. Semin Neurol 1993;13:256-63.
5. Vogel H. Inclusion body myositis. A review. Adv Anatom Pathol 1998;5:164-9.
6. Asakanas V, Engel WK. Sporadic inclusion body myositis and its similarities to an Alzheimer's disease brain. Scand J Rheumatol 1998;27:389-405.
7. Hilton-Jones D. Inflammatory muscle diseases. Curr Opin Neurol 2001;14:591-6.
8. Askanas V, Engel WK. Inclusion body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer's disease. J Neuropathol Exp Neurol 2001;60:1-14.
9. Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984;16:209-15.
10. Koffman BM, Rugiero M, Dalakas MC. Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve 1998;21:115-7.
11. Leff RL, Miller FW, Hicks J, Fraser DD, Plotz PH. The treatment of inclusion body myositis: a retrospective review and a randomized, prospective trial of immunosuppressive therapy. Medicine 1993;72:225-35.
12. Yamanishi Y, Maeda H, Katayama S, Ishioka S, Yamakido M. Scleroderma-polymyositis overlap syndrome associated with anti-Ku antibody and rimmed vacuole formation. J Rheumatol 1996;23:1991-4.
13. Soveidon SA, Dalaks ML. Treatment of inclusion body myositis with high-dose intravenous immunoglobulin. Neurology 1993;43: 876-9.